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Available online 6 January 2016Asrij is an endocytic protein expressed in mouse embryonic stem cells (mESCs) and is essential for maintenance
of stemness of mESCs (Mukhopadhyay et al., 2003; Sinha et al., 2013). Its human ortholog named Ovarian
Carcinoma Immuno-reactive Antigen domain containing protein 1 (OCIAD1) is 85% identical. We ectopically
expressed Asrij in epiblast stage equivalent-human embryonic stem cells (hESCs) to test for induction of naive
pluripotency in primed pluripotent cells. The construct pCAG-Asrij was introduced into hESCs bymicroporation.
Ectopic expression of Asrij in BJNhem20 hESC line was performed by selecting for plasmid transfection, followed
by stable cell line generation.
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BJNhem20-Asrij line was generated by transfection of BJNhem20
human embryonic stem cells (hESCs) with pCAG-Asrij construct usingAdvanced Scientiﬁc Research,
. This is an open access article undermicroporation technique with the conditions of 1100 V, 30 ms pulse
width and 1 pulse. The pCAG-Asrij construct was generated by cloning
Asrij Open Reading Frame amplicon from amino acids 1–247 between
Xho1 and Not1 sites using appropriate primers. A stable hESC line was
generated after subjecting these transfected cells to puromycin selec-
tion for two weeks.
Ectopic Asrij expression was validated by immunostaining and
Western blotting in three biological replicates.
Expression of pluripotent stem cell markers OCT4, SSEA3/4 and
TRA1-81 has been shown by immunostaining. Differentiation of these
hESC lines to all the three germ layers was demonstrated by immu-
nostaining for different markers such as AFP (endoderm), Brachyury
(mesoderm) and β-III tubulin (ectoderm).
Materials and methods
Cell culture
hESC line BJNhem20 was derived from discarded Grade III embryos
and tested for pluripotency (Inamdar et al., 2009). This cell line has
been cultured continuously for over 200 passages without acquiring
any karyotypic abnormality (Venu et al., 2010). The cell linewas includ-
ed in the analysis of genetic stability in the International StemCell Initia-
tive project (ISCI2, 2011). Cultures of BJNhem20 and the transgenic line
BJNhem20-Asrij were maintained on mouse embryonic ﬁbroblast
feeder layers in hESC medium composed of KnockOut Dulbecco's mod-
iﬁed Eagle medium (KO-DMEM-Life Technologies Cat no. 10829-018)
supplemented with 20% KnockOut Serum replacement (KOSR-Lifethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Expression and pluripotency analysis of BJNhem20-Asrij hESC line:— (A) Reverse transcriptase PCR showing ectopic expression of Asrij in BJNhem20-Asrij compared to its parental
line BJNhem20. (B)Western blot analysis showing overexpression of Asrij protein detected using OCIAD1 antibody (owing to its high sequence identity- 85%) as a lowermolecularweight
band below the endogenousOCIAD1protein band.More than three biological replicates have been analyzed for Asrij expression. (C) qRT-PCR analysis showing expression of pluripotency
marker genes Oct4, Nanog and Sox2 in Asrij overexpressing and wild type BJNhem20. (D) Immunostaining analysis of BJNhem20-Asrij for overexpression of Asrij and for pluripotency
markers Oct4, SSEA4 and TRA1-81 as indicated, compared to parental line BJNhem20 hESC line. The OCIAD1 antibody detects both OCIAD1 and Asrij. (E) Differentiation analysis of
BJNhem20-Asrij: Embryoid bodies stained to show differentiation to all the three germ layers by immunostaining for AFP, Brachyury and βIII-Tubulin marking the endoderm,
mesoderm and ectoderm respectively.
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no.35050-061), 1% non-essential amino acids (MEM-NEAA-Life Tech-
nologies Cat no.11140-050), 0.1% β-mercaptoethanol (Life Technol-
ogies Cat no.21985-023) and 8 ng/ml human recombinant basic
ﬁbroblast growth factor (human bFGF-Sigma Aldrich Pvt. Ltd. Cat
no. F-0291). These cells were routinely passaged by mechanical cut-
ting of undifferentiated colonies.
Microporation of hESCs to generate BJNhem20-Asrij cell line
For microporation, BJNhem20 cells were grown onMatrigel (Becton
Dickinson Catalog No. 354277) coated dishes till they were 70% conﬂu-
ent. The cells were trypsinized with 1X TrypLE (Life Technologies
Cat No.12605-010) at 37 °C for 4 min. The cells were pelleted by centri-
fugation at 1000 rpm for 2 min and washed with phosphate buffered
saline and enumerated. 0.5 million cells were resuspended in 10 μl of
R buffer and 6 μg of DNA was mixed and the cells were transfected in
a microporator (NeonMicroporation Kit-Life Technologies Cat no.
MPK1096). Microporation conditions used were 1100 V, 30 ms and 1
pulse according to the manufacturer's instructions. The cells were
then directly seeded onto Matrigel-coated dishes with mTESR media
(StemCell Technologies Cat no. 05850) supplementedwith ROCK inhib-
itor (10 μM Y-27632, Sigma Aldrich Pvt. Ltd. Cat no. Y0503) to aid
the survival of single cells. mTESR medium without ROCK inhibitor
was used after 12–16 h when the cells adhered. 48 h after transfection,
puromycin (0.5 μg/ml Sigma Aldrich Pvt. Ltd. P8833) was added to the
transfected culture and selectionwas continued for 2weeks. Puromycinresistant individual clones of transgenic Asrij overexpressing hESCs
were manually picked and passaged. BJNhem20-Asrij cells were subse-
quently cultured in both feeder free conditions on matrigel in the pres-
ence of mTESR medium and on feeders with regular hESC medium.
Embryoid body differentiation
Differentiation of embryoid bodies was carried out as described
before (Inamdar et al., 2009). Brieﬂy, colonies grown on MEFs were
mechanically cut and pieces cultured in human embryoid body media
(10% FBS-Hyclone-SH30070 with β-mercaptoethanol and GlutaMAX
in DMEM) on low attachment plates. These hESC aggregates were
allowed to grow in suspension for 3 days after which the colonies
formed embryoid body-like structures and were transferred to the tis-
sue culture dishes pre-treated with 0.1% gelatin and allowed to attach
and differentiate spontaneously till the time for harvest from day 6
onwards for immunostaining analyses.
Immunostaining
hESC and hEBs were ﬁxed in 2% paraformaldehyde (in PBS), perme-
abilized with Triton-X-100 (0.1% for cells and 0.3% for EBs) and then
blocked with 4% FBS for 1 h at RT (Room Temperature). Post blocking,
cells were incubatedwith the appropriate primary antibodies overnight
at 4 °C, thenwere washedwith PBS at RT and incubatedwith secondary
antibody conjugated to either Alexa Fluor 488 or 568 for 1 h at RT
(Dilution 1:400 Invitrogen). The cells were washed and stained using
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were acquired using an epiﬂuorescence microscope (IX-81 microscope
system (Olympus)) ﬁtted with a cooled CCD camera (CoolSnap, Roper
Scientiﬁc). Primary antibodies used were against OCIAD1 (Abcam
ab91574), Oct4 (BD Biosciences BD611203), TRA1-81 and SSEA4mono-
clonal antibodies were a kind gift from Peter Andrews (University
of Shefﬁeld, UK), Brachyury (Santa Cruz Biotech Cat no.SC-17743), β-
III tubulin, AFP (Sigma Chemical Pvt. Ltd. Cat no. A8452).
RNA isolation/cDNA synthesis and PCR
Total RNA was extracted from cells by TRIzol reagent (Life Technol-
ogies Cat no.15596-026) following themanufacturer's instructions. 2 μg
of DNase treated RNA was converted to cDNA by performing reverse
transcription using Superscript II (Life Technologies Cat no. 18064-
014). Quantitative Real time PCRwas performedusing EvaGreenMaster
Mix (Biorad). Primer sequences used for cDNA ampliﬁcation (5′–3′)
were as following:Primer nameo
o
n
n
ga
ga
so
so
mSequencect4_F GAAGGTATTCAGCCAAACGAC
ct4_R GTTACAGAACCACACTCGGA
anog_F TGCAAATGTCTTCTGCTGAGAT
anog_R GTTCAGGATGTTGGAGAGTTC
pdh_F GTCCATGCCATCACTGCCA
pdh_R TTACTCCTTGGAGCCATG
x2_F AGTCTCCAAGCGACGAAAAA
x2_R GCAAGAAGCCTCTCCTTGAA
AsrijHx1_F TTTGCAGAGTGCCATGAAGAGTGCTTCTGGTTC
AsrijHPh_R GACCGCAGTGGATCCCCAAGGGGGGAGTTTTCmWestern blot
For Western blot analysis, cells were pelleted, washed with 1X PBS,
lysed in lysis buffer for 4 h at 4 °C and clariﬁed by centrifugation at10,000 rpm for 20 min at 4 °C. Total protein was estimated using
Bradford reagent and 40 μg of lysate was loaded on a 12% SDS-PAGE
gel. The gel was electro-blotted onto Nitrocellulose membrane (PALL
corporation, USA) and incubated with primary antibody OCIAD1
(Abcam; Cat no., ab91574) at 4 °C (overnight), washed, then probed
with appropriate HRP-conjugated secondary antibody (Bangalore
Genei) for 1 h at RT and developed using ECL chemiluminescence kit
(Thermo Scientiﬁc, Rockford, IL, US).
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